{"id":3622,"date":"2021-03-11T11:57:45","date_gmt":"2021-03-11T11:57:45","guid":{"rendered":"https:\/\/www.neuraxpharm.com\/se\/?page_id=3622"},"modified":"2026-02-05T15:03:41","modified_gmt":"2026-02-05T15:03:41","slug":"multiple-sclerosis","status":"publish","type":"page","link":"https:\/\/www.neuraxpharm.com\/se\/neurological-disorders\/multiple-sclerosis\/","title":{"rendered":"Multiple sclerosis"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

\nMultiple Sclerosis<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t

\n\t\t\t\tIN THIS SECTION\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t<\/i>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Relaterade artiklar<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Inga data hittades<\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t

\n\t\t\t\tIN THIS SECTION\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t<\/i>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t
\n\t\t
Neuraxpharm <\/a><\/div>\n\t\t<\/div>\n\t\t<\/div>\n\t\t<\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Multiple sclerosis (MS) is a neurological condition affecting the nerves in the brain and spinal cord. It causes damage to the myelin sheath, the protective coating around the nerve fibres in the central nervous system.<\/p>

Neuraxpharm provides medication alternatives for the treatment of symptoms related to multiple sclerosis and once your doctor has determined your specific needs, they can prescribe the product that best adapts to your needs and condition.<\/p>

Find out more about the symptoms, risk factors, and how it is diagnosed and treated.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

What is multiple sclerosis (MS)?<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Multiple sclerosis (MS) is a chronic (long-term) condition that causes damage to the central nervous system, including the nerves in the brain, the spinal cord and the optic nerves. In MS, the immune system attacks the myelin sheath (the protective coating around the nerve fibres). This nerve damage interrupts the flow of messages from the central nervous system, causing a reduction or loss of body function. MS causes a wide range of symptoms, such as fatigue, walking difficulties, problems with vision, and thinking and planning issues.\u00a0In 40-70% of cases,\u00a0cognitive impairment<\/a>\u00a0can also be observed, in varied degrees of severeness among patients.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

What are the main types of MS?<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

There are three main types of MS. They are named according to how they affect the body over time:<\/p>

Relapsing-remitting MS (RRMS)<\/a>:<\/strong>\u00a0Most people diagnosed with MS (85%) have relapsing-remitting multiple sclerosis (RRMS) and experience the first signs of the disease in their early 20s. A person with RRMS will have periods when existing or new symptoms flare up aggressively; such a period is known as a relapse, flare-up, or exacerbation. Relapses often happen without any warning, although they can be stress-related or occur after an illness. They typically last a few days or weeks, and the symptoms then improve slowly over a similar time. The period between attacks, when symptoms disappear, is called remission. However, the MS is still active during these periods, and damage to the nerves may continue. After diagnosis, a person with MS will typically have relapses from time to time, followed by weeks, months, or even years of remission.<\/p>

Secondary progressive MS (SPMS):<\/strong>\u00a0If left untreated, up to 80% of people with RRMS are at risk of developing SPMS, however with treatment this number is much lower. This happens slowly, usually over a period of 10\u201315 years. In this phase, the old pattern of relapses followed by periods of remission usually stops. Some people may still get relapses, but they probably will not make a full recovery afterwards and will suffer some symptoms throughout. In SPMS, the symptoms gradually worsen over time. SPMS generally develops from RRMS, although a small number of people are diagnosed with SPMS at the outset.<\/p>

Primary progressive MS (PPMS):<\/strong>\u00a0About 15-20% of people with MS experience PPMS. The symptoms gradually worsen over time rather than appearing as relapses. It is called \u2018primary progressive\u2019 because it progresses from the first (primary) symptoms of the disease. There are no remissions, but there can be long periods of time when the condition seems to stabilise, with no noticeable changes.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

How many people have MS?<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

There are an estimated 2.1-2.2 million people with MS worldwide, and the condition is about two to three times more common in women than in men.<\/p>

According to the European Multiple Sclerosis Platform, across Europe, more than 700,000 people suffer from MS. This means that over one million people throughout the EU are affected by MS through their role as caregivers and family members.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Symptoms<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Everyone experiences MS differently. There is a wide range of symptoms, and they can vary from person to person, affecting different parts of the body.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

What are the symptoms of MS?<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

MS can cause many different symptoms and there is no typical pattern that applies to everyone. An early symptom for one person might never be experienced by someone else.<\/p>

However in general, some of the most common first symptoms are:<\/p>